Director Nicholas Liveris updates NOVONIX (NVX) shareholding in March Form 6-K

Rhea-AI Filing Summary

NOVONIX Limited filed a Form 6-K reporting an Appendix 3Y notice to the ASX about a change in a director’s shareholding. The notice shows director Nicholas Liveris now has a relevant interest in 589,142 ordinary shares held directly following an on-market trade.

The filing confirms there was no trading during a closed period that required prior written clearance.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2026

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No. Description

Exhibit 99.1 Appendix 3Y (Change of Director's Interest Notice) dated March 6, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED

By: /s/ Robert Long

       Robert Long

       Chief Executive Officer

Date: March 6, 2026

EXHIBIT 99.1

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NOVONIX LIMITED

ABN 54 157 690 830

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	NICHOLAS LIVERIS
Date of last notice	2 March 2026

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	3 March 2026
No. of securities held prior to change	659,090 Ordinary shares
Class	Ordinary shares
Number acquired	Nil
Number disposed	69,948 ordinary shares
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$23,782

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

EXHIBIT 99.1

Appendix 3Y

Change of Director’s Interest Notice

No. of securities held after change	589,142 Ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

EXHIBIT 99.1

Appendix 3Y Change of Director’s Interest Notice

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

FAQ

What does NOVONIX (NVX) disclose in this March 2026 Form 6-K?

NOVONIX’s Form 6-K discloses an Appendix 3Y notice about a change in director Nicholas Liveris’s shareholding. It reports his updated relevant interest in ordinary shares after an on-market trade, satisfying ASX listing rule 3.19A.2 and Corporations Act section 205G requirements.

How many NOVONIX (NVX) shares does director Nicholas Liveris hold after the change?

After the reported change, director Nicholas Liveris has a relevant interest in 589,142 NOVONIX ordinary shares held directly. This figure is disclosed in the Appendix 3Y attached to the Form 6-K, which records the updated position following an on-market trade on the Australian Securities Exchange.

Was the NOVONIX (NVX) director’s trade during a closed trading period?

The Appendix 3Y states the director’s interests were not traded during a closed period requiring prior written clearance. This indicates the on-market trade occurred outside any restricted trading window, aligning with the company’s and ASX’s governance and disclosure requirements for director dealings.

What is Appendix 3Y in NOVONIX (NVX) director dealings reporting?

Appendix 3Y is an ASX form used to report changes in a director’s relevant interests in a company’s securities. NOVONIX’s filing provides this notice for director Nicholas Liveris, detailing his direct holding of 589,142 ordinary shares after an on-market trade and confirming compliance information.

Which director is covered in NOVONIX (NVX)’s March 6, 2026 Appendix 3Y?

The March 6, 2026 Appendix 3Y relates to NOVONIX director Nicholas Liveris. It updates his relevant interest in the company’s ordinary shares after an on-market trade and notes his previous disclosure was dated March 2, 2026, ensuring continuity of director holding records.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 61.2 KB